On The Pen: The Weekly Dose
Claim This Podcastby Dave Knapp GLP-1 Industry Insider
Podcast Authority
Beta
Podcast Overview
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p>
Language
🇺🇲
Publishing Since
1/14/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for On The Pen: The Weekly Dose
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 8, 2026
Compound GLP-1 Poll STUNS THE INTERNET!
Host Dave explores why patients find compounded GLP-1s more effective, revealing insights into the patient experience rather than the drug itself.
June 23, 2026
How To Get $50 GLP-1
Obesity medicine expert Angela Fitch and host Dave Knapp discuss how Medicare beneficiaries can access GLP-1 medications for $50 monthly through the new Medicare Bridge Program.
June 16, 2026
What Comes After Zepbound? The Biggest ADA 2026 Obesity Drug Breakthroughs
Dave Knapp interviews Jen about the biggest ADA 2026 obesity drug breakthroughs, exploring molecules, trials, and results that will shape future metabolic disease treatments.
200 total episodes available with 106 transcripts
Recent guests on On The Pen: The Weekly Dose
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Angela Fitch
Guest
Jen
Guest
Sabina Hemme
Guest
Similar Podcasts
Discover related shows you might enjoy
GLP-1 Hub: Support, Community, and Weight Loss
Ana Reisdorf, MS, RD
The Plus SideZ: Cracking the Obesity Code
Kim Carlos
The Obesity Guide with Matthea Rentea MD
Matthea Rentea MD
Drop The Weight with Elizabeth McGann
Elizabeth McGann
Game-Changing Health
Gianna Beasley
The GLP-1 Podcast Show
Wisenetix
Fat Science
Dr Emily Cooper
Docs Who Lift
Docs Who Lift
The Hunter Williams Podcast
Hunter Williams
The Dr. Tyna Show
Dr. Tyna Moore
West Wellness & Longevity
Tara West
Peptide of The Week
JD Denham and Will Haas
The Peptide Podcast
The Peptide Queen
Today's discussion on unraveling BPC 157 Peptide
Infinity Peptides
Peptides for Women
Jennifer Woodward
Deep-dive analytics for On The Pen: The Weekly Dose
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is On The Pen: The Weekly Dose?
<p>On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.</p><p><br /></p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.